Company Profile
Wuhan NCE Biomedical Co.,Ltd is an innovative biomedical company with independent research and development capacities. It conducts high-level biochemical synthesis with a series of own intellectual property rights. Our company follows closely the industry trend, and the latest research achievements in life science area. Our main focus is to provide chemical custom synthesis services, and drug synthesis technology optimization services on the new chemical entity (NCE) products; and as well the high added-value medicine intermediate and drug development. We can provide premium tailor-made products to fit each customer need which ranging from grams to kilograms, by utilizing our highly efficient production process and our professional team. Our vision is to help the global customers to shorten their drug development cycle and reduce developm
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(2S)-1-(4-{[2-(2-Amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl}-1-piperazinyl)-2-hydroxy-1-propanone |
(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one;GNE 390;GDC-0980;(S)-1-(4-((2-(2-aMinopyriMidin-5-yl)-7-Methyl-4-Morpholinothieno[3,2-d]pyriMidin-6-yl)Methyl)piperazin-1-yl)-2-hydroxypropan-1-one;GDC-0980 (RG7422);Apitolisib;Apitolisib (GDC-0980, RG7422);(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one GNE 390GDC0980(RG7422) |
1032754-93-0 | - / 99% | Inquiry |
(2S)-N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-2-phenylglycine tert-butyl ester |
Glycine,N-[2-(3,5-difluorophenyl)acetyl]-L-alanyl-2-phenyl-,1,1-dimethylethyl ester,(2S)-;Glycine,N-[(3,5-difluorophenyl)acetyl]-L-alanyl-2-phenyl-,1,1-dimethylethyl ester,(2S)-;DAPT (enzyme inhibitor);DAPT;γ-Secretase inhibitor IX;GSI-IX;N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester;N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine tert-butyl ester;LY 374973 |
208255-80-5 | - / 99% | Inquiry |
(5E)-5-[[5-(4-Fluorophenyl)-2-furanyl]methylene] |
CAY10505;(5E)-5-[[5-(4-Fluorophenyl)-2-furanyl]methylene]-2,4-thiazolidinedione;(E)-5-((5-(4-fluorophenyl)furan-2-yl)methylene)thiazolidine-2,4-dione;CAY10505 ( 5E)-5-[[5-(4-Fluorophenyl)-2-furanyl]methylene]-2,4-thiazolidinedione;CAY10505, >=98% |
1218777-13-9 | - / 99% | Inquiry |
(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile maleate |
(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile (2Z)-2-butenedioate;(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile maleate;β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-(βR)-1H-pyrazole-1-propanenitrile, (2Z)-2-butenedioate);INCB018424 Maleic acid;WOJBKXOVBVZSET-HFNHQGOYSA-N |
1092939-15-5 | - / 99% | Inquiry |
(R)-5-Hydroxymethyl tolterodine |
Benzenemethanol,3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-;3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxybenzenemethanol;PNU 200577;5-Hydroxymethyltolterodine;(+)-N,N-Diisopropyl-3-(2-hydroxy-5-hydroxymethylphenyl)-3-phenylpropylamine;Desfesoterodine;SPM 7605;(R)-(+)-2-(3-Diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenol;2-[(1R)-3-[Di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenol;156755-19-0 |
207679-81-0 | - / 99% | Inquiry |
1,9-Pyrazoloanthrone |
Anthra[1,9-cd]pyrazol-6(2H)-one;C.I. 70300;Pyrazoleanthrone;1,9-Pyrazoloanthrone;Pyrazolanthrone;SP 600125;NSC 75890;2H-Dibenzo[cd,g]indazol-6-one;1PMV;JNK inhibitor II;420119 JNK inhibitor II;14,15-Diazatetracyclo[7.6.1.0[2,7].0[13,16]]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one |
129-56-6 | - / 99% | Inquiry |
1H-Pyrrole-1-hexanoicacid, 2,5-dihydro-2,5-dioxo-, [1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hy |
1H-Pyrrole-1-hexanoic acid,2,5-dihydro-2,5-dioxo-,2-[1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide;1H-Pyrrole-1-hexanoic acid,2,5-dihydro-2,5-dioxo-,[1-[4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide,(2S-cis)-;1H-Pyrrole-1-hexanoic acid,2,5-dihydro-2,5-dioxo-,[1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide;DOXO-EMCH;Doxorubicin-EMCH;1448631-80-8 |
151038-96-9 | - / 99% | Inquiry |
2-Fluoro-N-methyl-4-[7-[(quinolin-6-yl)methyl]im |
Benzamide,2-fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]-;2-Fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide;2-Fluoro-N-methyl-4-[7-[(quinolin-6-yl)methyl]imidazo[1,2-b]-[1,2,4]triazin-2-yl]benzamide;INCB 28060;Capmatinib;INC 280;NVP-INC 280NX;Tabrecta;1362837-07-7 |
1029712-80-8 | - / 99% | Inquiry |
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid |
GSK2636771;2-Methyl-1-[[2-Methyl-3-(trifluoroMethyl)phenyl]Methyl]-6-(4-Morpholinyl)-1H-benziMidazole-4-carboxylic acid;GSK2636771/GSK-2636771;1H-Benzimidazole-4-carboxylic acid, 2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-;2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acidGSK2636771;GSK 2636771 dihydrochloride;2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic;2-METHYL-1-[[2-METHYL-3-(TRIFLUOROMETHYL)PHENYL]METHYL]-6-MORPHOLIN-4-YLBENZIMIDAZOLE-4-CARBOXYLIC ACID |
1372540-25-4 | - / 99% | Inquiry |
2-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrole-3-propanoic acid |
1H-Pyrrole-3-propanoic acid,2-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-;2-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrole-3-propanoic acid;SU 5402;3-[3-(2-Carboxyethyl)-4-methylpyrrol-2-methylidenyl]-2-indolinone |
215543-92-3 | - / 99% | Inquiry |
2-[(3,4-Difluorophenyl)amino]-N-[2-methyl-5-(1-p |
GW791343 (trihydrochloride);2-(3,4-difluorophenylamino)-N-(2-methyl-5-(piperazin-1-ylmethyl)phenyl)acetamide trihydrochloride;GW791343 3HCl |
309712-55-8 | - / 99% | Inquiry |
3-(4-(Aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate |
LX-7101;LX7101;LX7101 HCL;UNII-74B3C4ZT96;CHEMBL3356433;74B3C4ZT96;HY-12659;LX7101 hydrochloride;3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate |
1192189-69-7 | - / 99% | Inquiry |
3-[[[3-[(Dimethylamino)methyl]phenyl]amino]pheny |
3-[[[3-[(Dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indole-6-carboxamide;BIX 02188;BIX 02188(BIX-02188;(Z)-3-((3-((dimethylamino)methyl)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxamide;3-[[[3-[(Dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indole-6-carboxamideBIX 02188;BIX 02188, >=98%;BIX-02188(Random Configuration) |
1094614-84-2 | - / 99% | Inquiry |
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline hydrochloride |
4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline hydrochloride;4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyriMidin-3-yl)quinoline HCl;LDN193189 (Hydrochloride);4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline hydrochloride (1:1);LDN-193189 HCl |
1062368-62-0 | - / 99% | Inquiry |
4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)am |
4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid;MLN9708;MLN9708,MLN-9708,MLN 9708;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acidMLN9708;Ixazomib Citrate;4-(Carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dio;MLN 9708 analog |
1201902-80-8 | - / 99% | Inquiry |
4-Iodo-3-nitrobenzamide |
Benzamide,4-iodo-3-nitro-;4-Iodo-3-nitrobenzamide;Iniparib;BSI 201;SML 0623;SAR240550;937799-96-7 |
160003-66-7 | - / 99% | Inquiry |
4-[(1E)-2-[5-[(1R)-1-(3,5-Dichloro-4-pyridinyl)e |
LY 2874455;(R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol;4-[(1E)-2-[5-[(1R)-1-(3,5-Dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]-1H-pyrazole-1-ethanol;LY2874455/LY-2874455;4-[(1E)-2-[5-[(1R)-1-(3,5-Dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]-1H-pyrazole-1-ethanol LY2874455;(R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethan-1-ol;(R,E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-yl)-ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl);(E)-2-(4-(2-(5-(1-(3,5-DICHLOROPYRIDIN-4-YL)ETHOXY)-1H-INDAZOL-3-YL)VINYL)-1H-PYRAZOL-1-YL)ETHANOL |
1254473-64-7 | - / 99% | Inquiry |
4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid |
Benzoic acid,4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy-;4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid;MLN 8237;Alisertib;1186318-95-5 |
1028486-01-2 | - / 99% | Inquiry |
5,6-Dimethylxantheonone-4-acetic acid |
9H-Xanthene-4-acetic acid,5,6-dimethyl-9-oxo-;5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid;5,6-Dimethylxanthenone-4-acetic acid;NSC 640488;DMXAA;AS 1404;5,6-Dimethyl-9-oxo-9H-xanthen-4-ylacetic acid;Vadimezan;ASA 404;2-(5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid;D5817;2-(5,6-Dimethyl-9-oxoxanthen-4-yl)acetic acid |
117570-53-3 | - / 99% | Inquiry |
6,7-Dimethoxy-4-[N-(3-bromophenyl)amino]quinazol |
4-Quinazolinamine,N-(3-bromophenyl)-6,7-dimethoxy-,hydrochloride (1:1);4-Quinazolinamine,N-(3-bromophenyl)-6,7-dimethoxy-,monohydrochloride;6,7-Dimethoxy-4-[N-(3-bromophenyl)amino]quinazoline hydrochloride |
183322-45-4 | - / 99% | Inquiry |
CONTACT INFORMATION
Sign In for Details